Related Experiment Video

Updated: Jun 8, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
04:36

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis

Published on: October 2, 2020

Biomarkers in predicting mortality and treatment in hemodialysis patients

Angela Yee-Moon Wang1

  • 1Department of Medicine, Queen Mary Hospital, University of Hong Kong 102 Pok Fu Lam Road Hong Kong.

F1000 Medicine Reports
|October 16, 2010
PubMed

Insights

Natriuretic peptides and cardiac troponin T (cTnT) are elevated in hemodialysis patients. This review explores their utility as biomarkers for predicting outcomes and guiding treatment in this population.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Circulating natriuretic peptides and cardiac troponin T (cTnT) are established biomarkers for cardiovascular conditions.
  • Elevated levels of these markers are common in end-stage renal disease (ESRD) patients.
  • This elevation poses a challenge for their diagnostic and prognostic utility in the ESRD population.

Purpose of the Study:

  • To review the current role of natriuretic peptides and cTnT.
  • To assess their predictive value for outcomes in hemodialysis patients.
  • To evaluate their utility in guiding treatment strategies for hemodialysis patients.

Main Methods:

  • Literature review of studies on natriuretic peptides and cTnT in hemodialysis.
  • Analysis of data regarding the association of these biomarkers with patient outcomes.
  • Synthesis of evidence on treatment implications.

Main Results:

  • Natriuretic peptides and cTnT levels are frequently elevated in hemodialysis patients.
  • Despite elevations, these biomarkers can retain prognostic value.
  • Specific cut-offs and interpretations may be necessary for this population.

Conclusions:

  • Natriuretic peptides and cTnT remain important, albeit complex, biomarkers in hemodialysis.
  • Further research is needed to refine their use in predicting outcomes and optimizing treatment.
  • Careful interpretation is crucial for leveraging their clinical utility in ESRD.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...